The emergence of antibiotic resistance driven in part by the overuse of broad-spectrum antibiotics represents a growing health crisis worldwide. This challenge is exacerbated by reduced financial incentives and regulatory challenges in the drug development pipeline. We are developing a precision antimicrobial initiative enabled by recent advancements in life science, material science, and data science to stay ahead on the drug resistance treadmill.
Pak Kin Wong | Biomedical Engineering | Mechanical and Nuclear Engineering